HealthEquity stock slides nearly 10% after 2027 outlook; JPM conference is next test
New York, Jan 12, 2026, 15:31 EST — Regular session Shares of HealthEquity dropped roughly 10% in Monday afternoon trading following the benefits administrator’s cautious initial fiscal 2027 outlook. The stock last traded down $9.53 at $84.62, hitting a session low around $84.51. This move is significant since HealthEquity’s longer-term targets often set the valuation benchmark for HSA custodians, whose…